Sign in

CIK 0001764013 · Large accelerated filer

Immunovant, Inc.

Sign in to watch
Ticker
IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
832771572
Phone
917-410-3120
Business address
1000 PARK FORTY PLAZA, DURHAM, NC, 27713
Former names
Health Sciences Acquisitions Corp
  1. FWP Offering Free Writing Prospectus
  2. DEFA14A Proxy Proxy Materials
  3. S-8 Other Securities Offered to Employees in Benefit Plans
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. DEFA14A Proxy Proxy Materials
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. S-8 Other Securities Offered to Employees in Benefit Plans
  8. EFFECT Other Notice of Effectiveness
  9. POS EX Other Post-effective Amendment
  10. EFFECT Other Notice of Effectiveness
  11. S-1MEF Other S-1MEF
  12. DRS Other Draft Registration Statement
  13. DEFA14A Proxy Proxy Materials
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. 25-NSE Other Notification of Removal from Listing
  16. EFFECT Other Notice of Effectiveness
  17. POS EX Other Post-effective Amendment
  18. S-1MEF Other S-1MEF
  19. EFFECT Other Notice of Effectiveness
  20. DRS Other Draft Registration Statement

Page 3 of 5 · 82 filings